The incidence of central serous chorioretinopathy in the population of Kazan: Results of a retrospective epidemiological analysis for 2009–2018
D. R. Аgliullin,
G. R. Khasanova,
E. A. Abdulaeva,
S. T. Agliullina,
A. N. Amirov,
A. N. Kuskov,
A. A. Kim,
A. Yu. Rascheskov,
D. A. Lipinskiy https://doi.org/10.34215/1609-1175-2020-3-30-33
Abstract
Objective: To assess the incidence of central serous chorioretinopathy (CSC) through the example of a large industrial Russian city.
Methods: A retrospective analysis of CSC of Kazan population for 2009–2018 has been done.
Results: From 2019 to 2018, 831 new cases of CSC were registered in Kazan. A statistically significant upward trend with growth rate 105.2% and accession rate 5.2% was typical for the annual track record. The mean age of patients was 50 years, the minimum age was 14 years, the maximum age was 87 years. A statistically significant upward trend was detected in track record of incidence in groups of 30–39-year-old and 40–49-year-old. Seasonal increase of the incidence was recorded in February, March, April, October, and November.
Conclusions: The upward trend and seasonal prevalence are typical for longterm morbidity of CSC in Kazan. The highest morbidity rate of CSC and statistically significant upward trend of its incidence in track record were recorded in the age of 30–39.
About the Authors
D. R. Аgliullin
Kazan State Medical University
Russian Federation
Russian Federation
MD, postgraduate student, Department of Epidemiology and Evidence Based Medicine,
49 Butlerova St., Kazan, 420012
G. R. Khasanova
Kazan State Medical University
Russian Federation
Russian Federation
MD, PhD, professor, head of the Department of Epidemiology and Evidence Based Medicine,
49 Butlerova St., Kazan, 420012
E. A. Abdulaeva
Kazan Branch of Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
MD, PhD, associate professor, head of the Department of Ophthalmology,
11 Mushtari St., Kazan, 420012
S. T. Agliullina
Kazan State Medical University
Russian Federation
Russian Federation
MD, PhD, associate professor, Department of Epidemiology and Evidence Based Medicine,
49 Butlerova St., Kazan, 420012
A. N. Amirov
Kazan Branch of Russian Medical Academy of Postgraduate Education
Russian Federation
Russian Federation
MD, PhD, associate professor, Department of Ophthalmology,
11 Mushtari St., Kazan, 420012
A. N. Kuskov
Republican Clinical Ophthalmological Hospital named after Professor E.V. Adamyuk
Russian Federation
Russian Federation
MD,
14 Butlerova St., Kazan, 420012
A. A. Kim
Ophthalmological Clinic “Kord Clinic”
Russian Federation
Russian Federation
MD,
82 Adelya Kutuya St., Kazan, 420073
A. Yu. Rascheskov
Ophthalmological Center “Eye Surgery Rascheskoff”
Russian Federation
Russian Federation
MD, PhD, chief,
28a Patrica Lumumba St., Kazan, 420081
D. A. Lipinskiy
Ophthalmological Clinic “Third Eye”
Russian Federation
Russian Federation
MD, PhD, chief,
3 Sportivnaya St., Kazan, 420073
References
1. Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070–80.
2. Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology. 2008;115:169–73.
3. Liegl R, Ulbig MW. Central serous chorioretinopathy. Ophthalmologica. 2014;232:65–76.
4. Tsai DC, Chen SJ, Huang CC. Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001–2006: A populationbased study. PLoS One. 2013. doi: 10.1371/journal.pone.0066858
5. Savilov ED, Astafyev VA, Zhdanova SN, Zarudnev EA. Epidemiologicheskiy analiz: Metody statisticheskoy obrabotki materiala. Novosibirsk: Nauka-Tsentr; 2011:156 (In Russ).
6. Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol. 2011;22(3):166–73.
7. Chan WM, Lai TY, Tano Y, Liu DT, Li KK, et al. Photodynamic therapy in macular diseases of asian populations: When East meets West. Jpn J Ophthalmol. 2006;50:161–9.
8. Desai UR, Alhalel AA, Campen TJ, Schiffman RM, Edwards PA, Jacobsen GR. Central serous chorioretinopathy in African Americans. J Natl Med Assoc. 2003;95(7):553–9.
9. Schatz H. Central serous chorioretinopathy and serous detachmentof the retinal pigment epithelium. Int Ophthalmol Clin. 1975;15:159–68.
10. Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clin Experiment Ophthalmol. 2013;41:201–14.
11. Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S. Risk factors for central serous chorioretinopathy: A case-control study. Ophthalmology. 2004;111:244–9.
12. Mateo-Montoya A, Mauget-Faÿse M. Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review. World J Gastrointest Pathophysiol. 2014;5:355–8.
13. Yannuzzi LA. Type A behavior and central serous chorioretinopathy. Retina. 2012;32:709.
14. Chatziralli I, Kabanarou SA, Parikakis E, Chatzirallis A, Xirou T, Mitropoulos P. Risk factors for central serous chorioretinopathy: Multivariate approach in a case-control study. Current Eye Research. 2017;42(7):1069–73.
15. Tsai DC, Chen SJ, Huang CC. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: A populationbased study in Taiwan. Retina. 2014;34:1867–74.
Review
For citations:
Аgliullin D.R., Khasanova G.R., Abdulaeva E.A., Agliullina S.T., Amirov A.N., Kuskov A.N., Kim A.A., Rascheskov A.Yu., Lipinskiy D.A. The incidence of central serous chorioretinopathy in the population of Kazan: Results of a retrospective epidemiological analysis for 2009–2018. Pacific Medical Journal. 2020;(3):30-33. (In Russ.) https://doi.org/10.34215/1609-1175-2020-3-30-33
Views:
610
Email this article 